Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M88,746Revenue (TTM) $M21,222Net Margin (%)12.9Altman Z-Score--
Enterprise Value $M88,746EPS (TTM) $2.6Operating Margin %17.4Piotroski F-Score--
P/E(ttm)31.2Beneish M-Score--Pre-tax Margin (%)15.9Higher ROA y-yN
Price/Book5.710-y EBITDA Growth Rate %11.6Quick Ratio--Cash flow > EarningsN
Price/Sales4.15-y EBITDA Growth Rate %-13.4Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow40.4y-y EBITDA Growth Rate %-25.5ROA % (ttm)7.6Higher Current Ratio y-yN
Dividend Yield %2.6PEG--ROE % (ttm)18.2Less Shares Outstanding y-yN
Payout Ratio %88.0Shares Outstanding M1,104ROIC % (ttm)15.2Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

LLY is held by these investors:



LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Zulueta Alfonso GSVP& Pres., Emerging Markets 2017-02-06Sell15,000$77.663.52view
Rice Derica WEVP-Global Services and CFO 2017-02-03Sell11,162$77.144.21view
Zakrowski Donald AChief Accounting Officer 2017-02-02Sell2,000$77.523.7view
LILLY ENDOWMENT INC10% Owner 2017-02-01Sell220,000$77.353.93view
Zakrowski Donald AChief Accounting Officer 2016-12-16Sell1,000$72.1311.45view
TAI JACKSON PDirector 2016-12-16Buy1,375$72.6410.67view
Mahony SusanSVP & Pres., Lilly Oncology 2016-12-16Sell20,242$72.6510.65view
HOOVER R DAVIDDirector 2016-12-16Buy500$71.8511.89view
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM 2016-12-16Sell2,093$82.23-2.24view
LILLY ENDOWMENT INC10% Owner 2016-12-16Sell200,000$72.5910.75view

Press Releases about LLY :

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
While Big Diabetes Stagnates, Smaller Companies Are Moving Faster Than Ever Feb 09 2017 
Eli Lilly’s Fiscal 2016 Earnings Feb 01 2017 
Top Insider Buys of the Week Dec 24 2016 
Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly Dec 10 2016 
52-Week Company Lows Nov 25 2016 
Novo Nordisk Is Being Ignored Oct 06 2016 
Sanofi Sues Merck Over Patent Infringement Sep 20 2016 
Eli Lilly's Future Is Changing Aug 30 2016 
Pharmaceuticals are the New Bonds Aug 30 2016 
Most Bought and Sold Stocks by Hedge Funds May 22 2016 

More From Other Websites
What's Driving Lilly's (LLY) Shares after 2016 Decline? Feb 16 2017
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Eli Lilly, T-Mobile, Oracle and Marathon... Feb 16 2017
DexCom Is a Great Healthcare Stock to Buy Now Feb 15 2017
Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show... Feb 15 2017
Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show... Feb 15 2017
Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next? Feb 15 2017
Incyte's (INCY) Beats on Q4 Earnings, Provides 2017 Outlook Feb 15 2017
Top Research Reports for Eli Lilly, T-Mobile US & Berkshire Hathaway Feb 15 2017
Eli Lilly Is Great Stock to Buy Now Feb 15 2017
Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip Feb 15 2017
Another Alzheimer's Drug Study Fails. This Time It's Merck's Feb 15 2017
Merck stopping late stage study as another Alzheimer's drug fails Feb 14 2017
Merck Stops Clinical Trial of Alzheimer's Drug Feb 14 2017
Merck to halt study of mild to moderate Alzheimer's drug Feb 14 2017
Lilly's Olumiant Gets Marketing Authorization in Europe Feb 14 2017
European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with... Feb 13 2017
European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with... Feb 13 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)